Colorimetric switchable linker-based bioassay for ultrasensitive detection of prostate-specific antigen as a cancer biomarker

Analyst. 2019 Jul 8;144(14):4439-4446. doi: 10.1039/c9an00552h.

Abstract

The use of colorimetric bioassays for protein detection is one of the most interesting diagnostic approaches, but their relatively poor detection limits have been a critical issue. In this study, we developed an efficient colorimetric bioassay based on switchable linkers (SLs) for the detection of prostate-specific antigen (PSA), which is one of the most widely used protein biomarkers for the diagnosis of prostate and breast cancers. SLs can cross-link gold nanoparticles (AuNPs) to generate large-scale aggregates and thereby induce precipitation to achieve visual signal amplification. In addition, when SLs are occupied by target proteins (referred to as 'switch-off'), highly sensitive detection is enabled. To maximize sensitivity, we adjusted the total surface area of AuNPs by controlling their concentration. As a result, PSA was detected at an ultralow concentration of 100 fg mL-1. This SL-based assay is shown to be simple, easy to handle and visualize, and highly sensitive. Therefore, in addition to PSA, the proposed SL-based assay could be used to detect other protein biomarkers.

MeSH terms

  • Antibodies, Monoclonal / immunology
  • Biomarkers, Tumor / blood*
  • Biomarkers, Tumor / immunology
  • Biosensing Techniques / methods
  • Colorimetry / methods
  • Gold / chemistry
  • Humans
  • Immunoassay / methods
  • Limit of Detection
  • Metal Nanoparticles / chemistry
  • Prostate-Specific Antigen / blood*
  • Prostate-Specific Antigen / immunology
  • Sensitivity and Specificity

Substances

  • Antibodies, Monoclonal
  • Biomarkers, Tumor
  • Gold
  • Prostate-Specific Antigen